Lorillard
File:Lorillard Logo.png | |
Company type | Public |
---|---|
NYSE:LO | |
Industry | Tobacco |
Founded | 1760 |
Founder | Pierre Lorillard |
Defunct | 2015 |
Fate | Acquired by Reynolds American |
Key people | Murray S. Kessler (CEO) |
Products | Cigarettes |
Revenue | $6.95 billion (2014) |
$1.78 billion (2014) | |
$1.19 billion (2014) | |
Number of employees | 2,900 (2014) |
Lorillard, Inc. was an American tobacco company that was founded in 1760 by Pierre Lorillard in New York City. It was the oldest continuously operating tobacco company in the United States until its acquisition by Reynolds American in 2015. Lorillard was known for its flagship brand, Newport, which was the top-selling menthol cigarette in the United States.
History[edit | edit source]
Lorillard was established in 1760 by Pierre Lorillard, a French immigrant, who began manufacturing snuff in a factory in New York City. The company expanded its product line to include chewing tobacco, cigars, and eventually cigarettes.
In the 19th century, Lorillard became a major player in the tobacco industry, and by the 20th century, it was one of the largest tobacco companies in the United States. The company was known for its innovative marketing strategies and was one of the first to use advertising to promote its products.
In 2014, Lorillard was acquired by Reynolds American, a subsidiary of British American Tobacco, in a deal valued at $27.4 billion. The acquisition was completed in 2015, and Lorillard's operations were integrated into Reynolds American.
Products[edit | edit source]
Lorillard's most famous product was the Newport brand, which was introduced in 1957. Newport quickly became popular for its menthol flavor and was particularly successful in urban markets. Other brands produced by Lorillard included Kent, True, and Old Gold.
Controversies[edit | edit source]
Like many tobacco companies, Lorillard faced numerous legal challenges and controversies related to the health effects of smoking. The company was involved in several lawsuits and was part of the Tobacco Master Settlement Agreement in 1998, which required tobacco companies to pay billions of dollars to states to cover healthcare costs related to smoking.
Acquisition by Reynolds American[edit | edit source]
In 2014, Reynolds American announced its intention to acquire Lorillard. The deal was part of a larger consolidation trend in the tobacco industry, as companies sought to increase their market share and reduce costs. The acquisition was completed in 2015, and Lorillard's brands were integrated into Reynolds American's portfolio.
Legacy[edit | edit source]
Lorillard's legacy is marked by its long history and its impact on the tobacco industry. The company's innovative marketing strategies and popular brands helped shape the modern tobacco market. Despite its controversies, Lorillard remains a significant part of American tobacco history.
Also see[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD